AsiaTIDES – Oligonucleotide and Peptide Research, Technology and Product Development
Conference - Tokyo, Japan
AsiaTIDES continues to be the premier forum to get a comprehensive update, meet key players and increase your knowledge of the oligonucleotide- and peptide-based therapeutics fields. The best forum to gain applied and basic knowledge, build your collaborative network, and learn skills to move your projects forward in one of today’s hottest research areas
A well-organized, informative meeting providing a great overview of the oligonucleotide field and the opportunity to network with current and potential collaborators in a nice setting. - Pamela A. Pavco, Ph.D., Chief Development Officer, RXi Pharmaceuticals, USA
Hear the latest reports from RXi, Tekmira, Santaris, miRagen,Arrowhead, REPLICor, PeptiDream, Ironwood,Pfizer, Immunovaccine, OncoTherapy Science, Zealand, Radius, Aileron and more. Learn manufacturing capabilities of all themajor oligonucleotide and peptide CMOs.
New Joint Session: OSWG and JPMA on Preclinical and Clinical Safety Assessment so You Can Plan Regulatory Strategies
(Courtesy of http://www.IBCLifeSciences.com/AsiaTIDES)
Tuesday, February 26, 2013 to Thursday, February 28, 2013 (9:00am - 17:00pm)
Sheraton Tokyo, Tokyo, Japan
Contact: Rita Parasurum (rita.parasurum@ibcasia.com.sg)
Phone: 65650824001
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
